C. Andrew Kistler, MD, PharmD, RPh

Andy Kistler MD, PharmD is a Gastroenterology and Hepatology Fellow at Thomas Jefferson University Hospital in Philadelphia, PA. He then earned his MD at Rutgers University-New Jersey Medical School in Newark, NJ. His research interests include the utilization of endoscopic procedures for GI malignancies, anticoagulation and C diff colitis.

Most Recent Articles by C. Andrew Kistler, MD, PharmD, RPh

Nutritional Challenges in Patients Post-Whipple Surgery

Nutritional Challenges in Patients Post-Whipple Surgery

By

Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.

Managing Gastrinomas: Evaluating Treatment Options

Managing Gastrinomas: Evaluating Treatment Options

By

Gastrinomas, rare endocrine tumors, can be treated in multiple ways, regardless of whether the tumor is resectable.

Searching for a Connection Between Multiple Myeloma and Autoimmune Disease

Searching for a Connection Between Multiple Myeloma and Autoimmune Disease

By

A number of studies have attempted to determine whether multiple myeloma is directly linked to autoimmune disease.

Biomarkers in Renal Cell Carcinoma: Evidence and Challenges

Biomarkers in Renal Cell Carcinoma: Evidence and Challenges

By

New and old biomarkers should be included in clinical trials to help build a database from which oncologists can draw sound clinical recommendations.

Ponatinib: Black Box Warning and Drug Interactions

Ponatinib: Black Box Warning and Drug Interactions

By

If a patient develops any adverse event while on ponatinib, clinicians should perform a risk-benefit analysis before deciding whether to continue treatment.

More Articles by C. Andrew Kistler, MD, PharmD, RPh

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters